Tookad (padeliporfin) / Steba Biotech  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tookad (padeliporfin) / ImPact Biotech
CLIN1601 PCM204 , NCT03315754: Study of the Efficacy, Safety and Quality of Life After TOOKAD® Soluble (VTP) for Intermediate Risk Prostate Cancer.

Active, not recruiting
2
50
US
TOOKAD Soluble 4 mg/kg, WST11
Steba Biotech S.A.
Localized Prostate Cancer
11/20
11/24

Download Options